Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection, COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05043623
What this trial is testing

Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior

Who this might be right for
SARS CoV 2 InfectionCOVID-19
Murdoch Childrens Research Institute 339
Not applicableStudy completedNCT04407559
What this trial is testing

COVID-SErology in Rheumatoid Arthritis (COVID-19)

Who this might be right for
COVID-19Rheumatoid Arthritis
University Hospital, Montpellier 216
Early research (Phase 1)Ended earlyNCT05101213
What this trial is testing

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegaloviral Infection+4 more
M.D. Anderson Cancer Center 12
Not applicableStudy completedNCT05827341
What this trial is testing

A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials

Who this might be right for
Malignant LymphomaClinical TrialCOVID-19
Sun Yat-sen University 110
Not applicableUnknownNCT05151094
What this trial is testing

Registry of Hospitalized Patients in University Hospital Dubrava Respiratory Center

Who this might be right for
Covid19ThrombosisBleeding+3 more
University Hospital Dubrava 6,000
Early research (Phase 1)UnknownNCT04469179
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19

Who this might be right for
COVID-19SARS-CoV2
SAb Biotherapeutics, Inc. 21
Not applicableStudy completedNCT04832061
What this trial is testing

Respiratory Supports and COVID-19 Mortality

Who this might be right for
COVID-19
Yale University 2,300
Not applicableLooking for participantsNCT05384561
What this trial is testing

Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

Who this might be right for
HyposmiaCOVID-19Parosmia+2 more
Université du Québec à Trois-Rivières 70
Large-scale testing (Phase 3)UnknownNCT05911061
What this trial is testing

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 4,950
Large-scale testing (Phase 3)Study completedNCT04880642
What this trial is testing

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects

Who this might be right for
COVID-19
Vicore Pharma AB 272
Post-approval studies (Phase 4)WithdrawnNCT04350086
What this trial is testing

Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection

Who this might be right for
COVID-19 InfectionSars-cov-2Respiratory Failure+1 more
University Hospital, Limoges
Testing effectiveness (Phase 2)WithdrawnNCT04502069
What this trial is testing

Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen

Who this might be right for
COVID-19Lung Infection
RedHill Biopharma Limited
Not applicableStudy completedNCT05576779
What this trial is testing

Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 2,101
Not applicableStudy completedNCT05697705
What this trial is testing

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study

Who this might be right for
COVID-19
AstraZeneca 188,814,085
Not applicableUnknownNCT05079373
What this trial is testing

Study of Neurological Damage From Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
University Hospital, Strasbourg, France 250
Post-approval studies (Phase 4)Looking for participantsNCT06441955
What this trial is testing

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

Who this might be right for
COVID-19, Long Haul
Well- Konnect Healthcare Services and Research Firm 100
Not applicableUnknownNCT04469153
What this trial is testing

Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19

Who this might be right for
the Prognostic Value of FerritinGlycosylated Ferritin in SARS-CoV-2 Infection in Hospitalized COVID-19 Patients
Hospices Civils de Lyon 57
Not applicableStudy completedNCT04785157
What this trial is testing

Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.

Who this might be right for
Covid19DeliriumPost-traumatic Stress Disorder
University Hospital, Toulouse 7
Large-scale testing (Phase 3)UnknownNCT04391101
What this trial is testing

Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-Cov-2
Hospital San Vicente Fundación 231
Not applicableStudy completedNCT05143567
What this trial is testing

Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications

Who this might be right for
Venous Thromboembolismcovid19Thrombosis
Ryazan State Medical University 150
Next Page